An interventional study of Music Care® device and EMONO in Low Back Pain and Anxiety, sponsored by Centre Hospitalier Universitaire de Nīmes. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-20.
Sponsored by Centre Hospitalier Universitaire de Nīmes · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes — 3 open to participants now, 3 under way, none of them phase 3. Low Back Pain · Centre Hospitalier Universitaire de Nīmes.
Among the 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes, this one is one of 2 that started in 2025, is one of 4 with no phase, and was the 12th registered.
2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.
Browse Low Back Pain studies →3 of the 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes are open now, in 1 country. Recruiting first, the newest first:
Centre Hospitalier Universitaire de Nīmes · Sites in France
Ages 18–65
Centre Hospitalier Universitaire de Nīmes · Sites in France
Ages 18+
By country, each count listing its studies:
Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 2 started in 2025.
This study's planned enrollment of 128 is above the median of 60 across 2,369 interventional studies indexed under Low Back Pain.
Median enrollment 38 across the 4 interventional studies, 85 across the 8 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Centre Hospitalier Universitaire de Nīmes is the lead sponsor of 595 studies on the registry; 87 are open to participants now.
2 of the studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05231265Centre Hospitalier Universitaire de NīmesEffect of Lumbar Surgery on Complexity During a Walking Task in Chronic Low Back Pain | 2027-04 |
| NCT06928740Centre Hospitalier Universitaire de NīmesEfficacy on Anxiety of the Digital Music Application Versus Equimolar Mixture of Oxygen and Nitrous Oxide in Patients Receiving CT-guided Lumbar Infiltration | 2027-06 |
Add all 2 to your calendar (.ics) → With an account.
Among the 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Since the Covid-19 crisis, patients appear more stressed, with increasing fear of exams and the hospital environment, in particular for CT scan teams, which require injections. Currently, an equimolar mixture of oxygen and nitrous oxide (EMONO) is used to calm patients. However, the patient's prone position complicates its use, with patients sometimes in painful position and the discomfort of gas inhalation (nausea, dizziness, etc.), as well as reduced lung capacity. Greater patient anxiety increases the risk of complications, or even failure, (unexpected movement, stiffness, refusal to complete the procedure, etc.). In this study, music therapy using Music Care® tablets, was tested to replace EMONO. The study authors hypothesize that the use of the Music Care® device will have a comparable efficacy to that of EMONO (non-inferiority) in reducing patient anxiety during CT-guided lumbar infiltration. Furthermore, the study authors hypothesize that this simple, non-invasive method, with no contraindications for the patient, will be better tolerated and appreciated by both the patient and the paramedical team in charge of the treatment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Music Care® device
Other: EMONO
Installation of the Music Care® device, selection of the sequence based on the patient's musical taste, listening to at least 20-minute sequence in the preparation room. Once placed on the scanner table, the patient listens to the same sequence as in the preparation room.
Equimolar mixture of oxygen and nitrous oxide given as usual care
Anxiety between groups
0-100 visual analog scale (VSA)
Time frame: Baseline
Anxiety between groups
0-100 visual analog scale (VSA)
Time frame: Day 0: upon locating helix and a skin location
Anxiety between groups
0-100 visual analog scale (VSA)
Time frame: Day 0: before injection of corticosteroids
Patient satisfaction between groups
0-100 visual analog scale (VSA)
Time frame: Day 0: Before discharge from imagery department
Patient comfort between groups
0-100 visual analog scale (VSA)
Time frame: Day 0: After injection of corticosteroids
Patient-reported pain between groups
0-100 visual analog scale (VSA)
Time frame: Day 0: Before injection of corticosteroids
Patient-reported pain between groups
0-100 visual analog scale (VSA)
Time frame: Day 0: After injection of corticosteroids
Anxiety between groups according to type of injection (foraminal, pudendal or posterior articular)
0-100 visual analog scale (VSA)
Time frame: Day 0: Before injection of corticosteroids
Anxiety between groups according to type of injection (foraminal, pudendal or posterior, articular, epidural, sacroiliac joints, and sacrococcygeal hiatus)
0-100 visual analog scale (VSA)
Time frame: Day 0: After injection of corticosteroids
Satisfaction of radiographer between groups
0-100 visual analog scale (VSA)
Time frame: Day 0
Rate of adverse events between groups
According to Common Terminology Criteria for Adverse Events version 5.0 (grade 1-5)
Time frame: Day 0: During procedure
Rate of adverse events between groups
According to Common Terminology Criteria for Adverse Events version 5.0 (grade 1-5)
Time frame: Day 0: immediately after procedure
Rate of complications between groups
According to Clavien-Dindo (grade I-V)
Time frame: Day 0: During procedure
Rate of complications between groups
According to Clavien-Dindo (grade I-V)
Time frame: Day 0: immediately after procedure
Started Oct 2025 (actual). Primary completion is estimated for Jun 2027, 20 months after the start.
Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 20 months is above that.
Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de Nīmes →